Manpreet Mundi
mmundi.bsky.social
Manpreet Mundi
@mmundi.bsky.social
Professor of Medicine with clinical and research focus in obesity as well as inpatient and outpatient nutrition support.
Reposted by Manpreet Mundi
Dr. Mundi @mmundi.bsky.social presenting about GLP-1 at the annual KYSPEN meeting.
September 27, 2025 at 12:02 AM
Reposted by Manpreet Mundi
Orforglipron, small molecule GLP-1ra in type 2 #diabetes.
➡️mean HbA1c at baseline was 8.0%. At week 40, it dropped −1.24% with 3-mg, −1.47 % with 12-mg, −1.48 % with 36-mg dose, and −0.41 % with placebo.

www.nejm.org/doi/full/10....

#ADA2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes | NEJM
Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...
www.nejm.org
June 22, 2025 at 1:04 AM
A consequence of climate change being worsening sleep apnea is something I never even considered. 🍎🧪
A study in Nature Communications quantifies how rising temperatures linked to climate change would increase the severity of obstructive sleep apnea (OSA) and reports projected losses of healthy life years and workplace productivity due to OSA. go.nature.com/3HMqsMg #medsky 🧪
June 22, 2025 at 9:21 PM
Our toolbox for management of #obesity continues to grow with phase 3 data being released today for the combination of cagrilinitide and semaglutide. Average weight loss for the combined drugs was over 20% and side-effect profile was similar to semaglutide. #Medsky 🧪🍎 www.nejm.org/doi/full/10....
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity | NEJM
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials; the efficacy of the ...
www.nejm.org
June 22, 2025 at 9:15 PM
Reposted by Manpreet Mundi
June 21, 2025 at 4:08 PM
Reposted by Manpreet Mundi
If you're trying to build muscle, getting enough protein is a must. But does it matter if that protein comes from meat or plants? A new study overturns assumptions.
Protein for strength training? Vegan diet matches meat for muscle gains
If you're trying to build muscle, getting enough protein is a must. But does it matter if that protein comes from meat or plants? A new study overturns assumptions.
www.npr.org
May 19, 2025 at 9:49 PM
Analysis of Epic Cosmos data shows use of semaglutide and tirzepatide continues to increase for management of #Obesity now at 2.3% of eligible adults. Discrepancies in prescribing remain based on race and where you live. #Medsky

jamanetwork.com/journals/jam...
Semaglutide and Tirzepatide Prescribing for Obesity
This study uses data from the US nationwide electronic health record–based Epic Cosmos Dataset to examine prescriptions for semaglutide and tirzepatide, focusing on differences across race, ethnicity,...
jamanetwork.com
May 4, 2025 at 6:16 PM
This is such a tremendous loss for nutrition and obesity research. Truly hope you are able to continue your work elsewhere especially in Ultra-processed foods.
After 21 years at my dream job, I’m very sad to announce my early retirement from the National Institutes of Health. My life’s work has been to scientifically study how our food environment affects what we eat, and how what we eat affects our physiology.
April 16, 2025 at 11:19 PM
Reposted by Manpreet Mundi
Sedentary Behavior and Light-Intensity Physical Activity During Pregnancy and Cardiovascular Health: A Science Advisory From the American Heart Association.

www.ahajournals.org/doi/epub/10....

@ahajournals.bsky.social @ahascience.bsky.social
#CardioSky #MedSky #Circulation
April 10, 2025 at 12:26 PM
Reposted by Manpreet Mundi
(1/n) Why is it so hard to stop eating when something tastes amazing? Our new @ science.org paper reveals that dopamine helps sustain our drive for tasty treats—and may explain how anti-obesity Ozempic tames those urges. doi.org/10.1126/science.adt0773
March 30, 2025 at 2:54 AM
Do artificial sweeteners increase our appetite? This study using fMRI seems to show that artificial sweeteners activate key regions of the hypothalamus that regulate appetite. #Medsky #Obesity 🧪🍎
www.nature.com/articles/s42...
Non-caloric sweetener effects on brain appetite regulation in individuals across varying body weights - Nature Metabolism
In a randomized, crossover clinical trial in healthy young adults with varying weights, sucralose increased hypothalamic blood flow and its functional connections with brain regions involved in motiva...
www.nature.com
March 30, 2025 at 5:55 AM
Reposted by Manpreet Mundi
This is such an amazing study. Researchers tracked people over 300,000 births looking at how biomarkers change & recover postpartum. ~60% stabilise close to pre-conception levels after 3 months, but some (eg for bone & liver health) take a year. Others never recover! 🧪 www.nature.com/articles/d41...
Gigantic birth study paints most detailed picture of pregnancy’s toll on body
Data from 300,000 births reveal how essential biological measurements are altered by carrying and delivering a baby.
www.nature.com
March 27, 2025 at 9:44 AM
Are tirzepatide and semaglutide cost effective? Although they would reduce 20,854 & 19,211 cases of DM2 and 10,655 and 8263 cases of CVD per 100K respectively, their prices would require a 30.5% and 81.9% reduction from current price to be “cost-effective" #Medsky 🧪

jamanetwork.com/journals/jam...
Lifetime Health Effects and Cost-Effectiveness of Tirzepatide and Semaglutide in US Adults
This study compares the cost-effectiveness of 4 antiobesity medications (naltrexone-bupropion, phentermine-topiramate, semaglutide, or tirzepatide) with lifestyle modification vs lifestyle modificatio...
jamanetwork.com
March 15, 2025 at 11:43 PM
Reposted by Manpreet Mundi
adiposetissue.org: A knowledge portal integrating clinical and experim... www.sciencedirect.com/science/arti... Thanks to the authors for providing a great online tool for the community
AT Knowledge Portal
adiposetissue.org
February 21, 2025 at 11:06 AM
We do see similar rapid weight loss with bariatric surgery. So medication selection, ie the correct medication based on BMI and medical co-morbidities will be key. 🧪 #obesity #Medsky
February 20, 2025 at 9:34 PM
Great review on cardiovascular fitness. Imagine if VO2 max was a vital sign measured annually. #Nutsky 🧪🍎
nejm.org NEJM.org @nejm.org · Feb 18
Cardiorespiratory fitness is an indicator of future cardiac, metabolic, and health events and is a strong predictor of all-cause mortality. Brazile et al. review the basics of the cardiorespiratory response to exercise. Full article in NEJM Evidence: eviden.cc/3Pe9Ay8

#MedSky #CardioSky #PulmSky
February 19, 2025 at 12:25 PM
Looking forward to ASPEN 2025. See you in Columbus.
Anyone else attending the ASPEN conference next month? It will be interesting to hear how NIH cuts and other cuts have affected nutrition research. #nutsky
February 17, 2025 at 2:18 PM
Our review on Short chain fatty acids was just published. SCFA were once thought to just influence the gut mucosa locally, but now appear to have systemic effects: immune-modulation, anti-inflammatory, appetite suppression, mitochondrial function, etc.

#MedSky 🍎🧪
journals.lww.com/co-clinicaln...
Short-chain fatty acids in clinical practice: where are we? : Current Opinion in Clinical Nutrition & Metabolic Care
lued dietary substrate. Recent findings SCFAs act systemically through stimulation of G protein receptors (GPRs) and inhibition of histone deacetylases (HDACs). SCFAs cause appetite suppression, re...
journals.lww.com
February 12, 2025 at 4:55 PM
Are GLP-1 receptor agonists associated with higher risk of thyroid cancer. It looks like there is only an increase in the first year most likely due to increased vigilance. Overall no increase compared to other diabetes medications. #Medsky #Obesity 🧪

jamanetwork.com/journals/jam...
GLP-1RA Use and Thyroid Cancer Risk
This secondary analysis of a target trial emulation of a comparative effectiveness study uses claims data to estimate the risk of incident thyroid cancer in adults with type 2 diabetes starting treatm...
jamanetwork.com
February 5, 2025 at 2:18 PM
Hope to see ongoing research about the impact of microplastics.
Tiny plastic particles may accumulate at higher levels in the human brain than in the kidney and liver, with greater concentrations detected in postmortem samples from 2024 than in those from 2016, suggests a paper in Nature Medicine. https://go.nature.com/414lf9S #Medsky 🧪
February 4, 2025 at 4:17 PM
Thanks for raising this issue. Really important to set social media curfew before bedtime especially in current political climate. #Medsky 🧪
1/ Ever scrolled through social media late at night, only to feel more anxious & unable to sleep? 😵‍💫 You're not alone. Let's talk about how seeing stressful or disturbing content affects sleep and what you can do about it. 🧵👇 #SleepHealth
February 4, 2025 at 4:14 PM
Reposted by Manpreet Mundi
Sugar-sweetened beverages are associated with an increased risk of Type 2 diabetes. Now we may know why.
Changes in the gut microbiome and its metabolites
www.cell.com/cell-metabol...
January 31, 2025 at 3:38 PM